Viral kinetics in adults with Covid-19 treated with nirmatrelvir-ritonavir or molnupiravir: a population-based, observational cohort study. [PDF]
Prager M +16 more
europepmc +1 more source
Medication errors and associated serious outcomes in COVID-19 antivirals: a real-world study based on FDA Adverse Event Reporting System database. [PDF]
Xiong X, Chen Z, Yan B.
europepmc +1 more source
Designing Novel Compound Candidates Against SARS-CoV-2 Using Generative Deep Neural Networks and Cheminformatics. [PDF]
Li SY, Hung CM, Hung HY, Lai CW, Lee MC.
europepmc +1 more source
Effectiveness of nirmatrelvir/ritonavir and molnupiravir in reducing the risk of short-term and long-term cardiovascular complications of COVID-19: a target trial emulation study. [PDF]
Guo Z +16 more
europepmc +1 more source
On the ozonation of anti-SARS-CoV-2 substances and their nucleoside analogues for mechanistic understanding of the ozone induced transformation using HPLC-ESI-Q-TOF-HRMS. [PDF]
Bartels I +3 more
europepmc +1 more source
Inhibitory effects of molnupiravir on Crimean-Congo hemorrhagic fever virus polymerase. [PDF]
Sloan A +11 more
europepmc +1 more source
Repurposing of FDA-Approved Antiviral Drugs Against Monkeypox Virus: Comparative In Vitro Screening and Structure Based In Silico Studies. [PDF]
Moatasim Y +9 more
europepmc +1 more source
Nucleoside analogue EIDD-1931 in the treatment of naturally occurring feline infectious peritonitis. [PDF]
Kennedy A, White J.
europepmc +1 more source
Comparing the Effectiveness and Safety of Remdesivir and Molnupiravir in COVID-19: A Systematic Review and Meta-Analysis. [PDF]
Moghadam SHP +5 more
europepmc +1 more source
Efficacy of Oseltamivir Against Seasonal Influenza H1N1 and the Efficacy of a Novel Combination Treatment In Vitro and In Vivo in Mouse Studies. [PDF]
Liu D +9 more
europepmc +1 more source

